• Targeting Cdc42 to Mitigate Kidney Fibrosis: New Insights fr

  2026-04-21

  This study identifies the natural compound daphnepedunin A as a direct inhibitor of Cdc42, demonstrating potent anti-fibrotic effects in kidney disease models. By disrupting Cdc42-mediated GSK-3β/β-catenin signaling, the research provides a mechanistic basis for targeting Cdc42 in chronic kidney disease and advances the rationale for selective Cdc42 inhibition in fibrosis research.

• Polybrene (Hexadimethrine Bromide): Optimizing Gene Delivery

  2026-04-21

  Polybrene (Hexadimethrine Bromide) 10 mg/mL from APExBIO is a benchmark enhancer of viral gene transduction and lipid-mediated DNA transfection, with applications extending to precision peptide sequencing. This article details evidence-backed workflows, practical troubleshooting, and the latest insights from bench research to maximize assay success and reproducibility.

• Advancing In Vitro Drug Response Assessment in Cancer Resear

  2026-04-20

  Schwartz’s dissertation critically evaluates how in vitro assays measure anti-cancer drug effects, distinguishing between proliferation inhibition and cell death. The work clarifies methodological choices, revealing that most compounds—including apoptosis and survivin inhibitors—invoke both growth arrest and cytotoxicity, but to different extents and with varying kinetics. These insights strengthen preclinical assay design and interpretation for oncology research.

• Q-VD-OPh: Pan-Caspase Inhibitor for Advanced Apoptosis Resea

  2026-04-20

  Q-VD-OPh empowers apoptosis research with broad-spectrum, irreversible caspase inhibition, enabling both in vitro and in vivo studies of cell death pathways and neurodegeneration. Its cell and brain permeability, high potency, and proven applications in cryopreservation and disease models set it apart for experimental rigor.

• Targeted mRNA Nanoparticles Restore BBB After Ischemic Strok

  2026-04-19

  This study demonstrates that lipid nanoparticles can deliver IL-10-encoding mRNA to ischemic brain regions, promoting microglial M2 polarization and repairing the blood–brain barrier after stroke. The findings highlight a new targeted mRNA delivery platform with translational potential for neuroinflammation and stroke therapies.

• Protoporphyrin IX: Photodynamic Compound for Heme Assays

  2026-04-18

  Protoporphyrin IX is a pivotal photodynamic compound enabling high-fidelity modeling of heme biosynthesis, ferroptosis, and cancer diagnostics. APExBIO's high-purity grade ensures reproducibility in workflows ranging from iron chelation studies to advanced photodynamic therapy research.

• TCAIM Regulates Mitochondrial Metabolism by Targeting OGDH

  2026-04-17

  Wang et al. (2025) identify TCAIM as a mitochondrial DNAJC co-chaperone that uniquely binds and reduces α-ketoglutarate dehydrogenase (OGDH) protein levels, revealing a novel post-translational regulatory mechanism affecting the TCA cycle. These findings highlight the role of mitochondrial proteostasis in metabolic regulation and open new avenues for investigating metabolic disorders.

• Moesin as a Biomarker of Endothelial Injury in Sepsis: Evide

  2026-04-16

  This study establishes moesin (MSN) as a novel biomarker for endothelial injury severity in sepsis, demonstrating mechanistic links to vascular inflammation and permeability via Rock1/MLC and NF-κB signaling. These findings have direct implications for the early assessment of sepsis severity and open new avenues for vascular injury research.

• Neem Leaf Extract Extends Lifespan and Reduces Oxidative Str

  2026-04-15

  Dang et al. (2024) systematically demonstrate that neem leaf extract (NLE) extends chronological lifespan and improves oxidative stress resistance in yeast and human cell models. Their work reveals that flavonoid-enriched NLE modulates oxidoreductase pathways, notably upregulating catalase (CTT1), and provides mechanistic insight into traditional claims of neem's anti-aging properties.

• EGCG-Functionalized Hydrogel Microspheres for IVDD Therapy

  2026-04-14

  This study presents a dual-network hydrogel microsphere system functionalized with (-)-Epigallocatechin gallate (EGCG) and microRNA cargo for targeted modulation of inflammation and apoptosis in intervertebral disc degeneration (IVDD). The platform demonstrates stimulus-responsive delivery and restoration of nucleus pulposus cell function, offering a promising strategy for IVDD management.

• Perphenazine: Dopamine D2 Antagonist for Advanced Research

  2026-04-13

  Perphenazine stands out as a versatile dopamine D2 receptor antagonist, now at the forefront of both neuropharmacology and host-directed antibacterial research. Its unique receptor profile and mitochondria-mediated cell death induction provide researchers with reproducible, high-impact workflows for studying psychosis, immune modulation, and beyond.

• Kanamycin Sulfate: Precision and Pitfalls in Antibiotic Assa

  2026-04-12

  Explore Kanamycin Sulfate as a water-soluble antibiotic with a focus on assay reliability, selection fidelity, and interpretive limitations. This article uniquely dissects how experimental parameters and comparative evidence inform best practices for advanced antibiotic resistance research.

• Optimizing DNA Repair Inhibition with ABT-888 (Veliparib)

  2026-04-12

  ABT-888 (Veliparib) empowers researchers to precisely modulate DNA repair inhibition and amplify chemotherapy or radiation effects in MSI and DNA repair-deficient cancer models. This article delivers stepwise protocols, advanced assay integration, and troubleshooting insights to maximize reproducibility in translational oncology workflows.

• Perifosine (KRX-0401): Applied Workflows for Akt Pathway Inh

  2026-04-11

  Perifosine (KRX-0401) is a synthetic Akt inhibitor enabling reproducible apoptosis assays, radiosensitization studies, and advanced Akt/mTOR pathway research across cancer and neuroprotection domains. This article dissects streamlined experimental protocols, highlights troubleshooting essentials, and translates the latest reference findings into actionable laboratory strategies.

• Cyclo (-RGDfC): Optimizing Integrin-Mediated Tumor Targeting

  2026-04-11

  Cyclo (-RGDfC) enables robust, reproducible integrin αvβ3 targeting for high-precision tumor research. Discover stepwise workflow enhancements, practical troubleshooting, and real-world assay insights that set this cyclic peptide apart for cancer and angiogenesis studies.

454 records 21/31 page Previous Next First page 上5页 2122232425 下5页 Last page